Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)

NCT06134622 is registered in ClinicalTrials.gov with The First Affiliated Hospital of University of Science and Technology of China as lead sponsor.

NCT NCT06134622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06134622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)
Lead sponsor
The First Affiliated Hospital of University of Science and Technology of China
Phase
Phase 3
Overall status
Completed
Start date
March 14, 2024
Completion date
December 30, 2024
Enrollment
832 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke